{"DataElement":{"publicId":"2001353","version":"4","preferredName":"Southwest Oncology Group Malignant Neoplasm Other Protocol Specify","preferredDefinition":"the free text field to specify the malignant neoplasm of another Southwest Oncology Group (SWOG) protocol.","longName":"SWOG_CA_O_PROT_SPEC","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2322464","version":"1","preferredName":"Southwest Oncology Group Malignant Neoplasm Other Protocol","preferredDefinition":"information related to cancer on another southwest oncology group protocol.","longName":"SWOG_CA_O_PROT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2322461","version":"1","preferredName":"Southwest Oncology Group Malignant Neoplasm","preferredDefinition":"The Southwest Oncology Group (SWOG) is an NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956 and is headquartered in San Antonio, TX. Its network consists of almost 4,000 of the physicians at 283 institutions throughout the US and Canada. The major goal of the SWOG since 1990 has been to enroll more women and minority patients in cancer treatment and control research trials.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25699:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Southwest Oncology Group","conceptCode":"C25699","definition":"An NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956 and is headquartered in San Antonio, TX. Its network consists of almost 4,000 of the physicians at 283 institutions throughout the US and Canada. The major goal of the SWOG since 1990 has been to enroll more women and minority patients in cancer treatment and control research trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-06B5-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-03","modifiedBy":"ONEDATA","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322462","version":"1","preferredName":"Other Protocol","preferredDefinition":"Not otherwise specified.:An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"C17649:C25320","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-06B9-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-03","modifiedBy":"ONEDATA","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-21D3-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018806","version":"1","preferredName":"Assessment Specify","preferredDefinition":"The free text field to specify the assessment performed.","longName":"ASSESS_SPEC","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B9698B67-5B33-24B9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-14","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-21","modifiedBy":"KNABLEJ","dateModified":"2017-08-23","changeDescription":"8/23/17 jk added registration status and CSI per Round 5 finalization task; capitalized first word in definition. --- released","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"2001445","type":"HISTORICAL_CDE_ID","context":"CTEP"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Cancer of other SWOG study, specify cancer","url":null,"context":"CTEP"},{"name":"Cancer of other SWOG study, s","type":"Preferred Question Text","description":"Cancer of other SWOG study, specify cancer","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDB84DD5-82B9-316D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-15","modifiedBy":"CAMPBELB","dateModified":"2007-10-17","changeDescription":"No Effective Begin Date --- Lung Change Management 09/07","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}